Direct immunologic activities of CpG DNA and implications for gene therapy.
about
Progress towards gene therapy for cystic fibrosisPhosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivoDNA vaccination protects mice against Zika virus-induced damage to the testesAnticytokine gene therapy of autoimmune diseases.Transient depletion of kupffer cells leads to enhanced transgene expression in rat liver following retrograde intrabiliary infusion of plasmid DNA and DNA nanoparticles.Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy.Emerging vectors and targeting methods for nonviral gene therapy.Nonviral gene delivery: what we know and what is next.Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma.Towards effective non-viral gene delivery vector.The liver as a target organ for gene therapy: state of the art, challenges, and future perspectives.Luciferase therapeutic microcapsules for gene therapy.Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy.TLR9 and IRF3 cooperate to induce a systemic inflammatory response in mice injected with liposome:DNA.Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway.Effects of Cellular Methylation on Transgene Expression and Site-Specific Integration of Adeno-Associated Virus.Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers.An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy.Time course of gene expression after plasmid DNA gene transfer to the liver.Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation.Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity.Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis.
P2860
Q22306014-0A8152BD-AB0A-4D3D-86AB-7FC2EC6A9708Q24682799-6EBDD70A-0781-4021-9ECE-1068D90B3872Q30855414-5D891DF0-FCF9-4E1B-A165-E58C7FA0817CQ34451949-BC6EA05E-AA3E-4B8E-A1E1-82BC95D1FCA4Q35101995-68B50080-5184-4514-AC07-C9E8395723AFQ36068780-CB8AAECC-6605-4F3B-B05C-4D3D6CDAFA3EQ36316635-70642645-5125-43B3-9A3D-7FE6B7F1F9F0Q36580613-8FF192A8-C07F-457A-84DA-4744A2E6D6F8Q36780064-D0103940-A7E2-4062-9CDF-210079A098E8Q36990647-1B4B74DD-DB72-4E6D-87D9-1345D0EAD567Q37398200-54A25C2F-7C91-4487-9292-7731B6D6DB5BQ37664701-2064E836-9F87-4CEB-9DFB-91BBD261F3D4Q38830057-705F23D0-B83B-42CA-A927-8680D879C40DQ39669977-1D34A2F1-95BD-4A15-AA64-4972864A0598Q39773340-E03A8A50-2B59-4FEA-AE79-E752154D374FQ40038726-4665761F-C89A-4B16-A7BC-0ECCA194EA79Q40295059-B19AA78F-6B8B-40DD-A837-09F4A7D26AB8Q40752695-4368540A-7F0D-4D76-B890-A3F83064668CQ41673539-A4DCDDD8-87A4-40DA-9356-F37B711A51B0Q41762712-5BBD7009-B053-4BB9-A093-BEE0366966F2Q43576553-0CDF1163-03FE-4512-876D-E45B46653F85Q43843248-1B06F0CA-71F4-4C7F-8E15-80D369E73D01Q45855260-42C78E85-5152-4CBF-B782-757C7DB75427Q45877903-73CB2442-7696-4020-9398-8BF8D2B2DA58Q45886686-F4C9A3A6-C402-4DB7-AD23-6E4A21856D94
P2860
Direct immunologic activities of CpG DNA and implications for gene therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Direct immunologic activities of CpG DNA and implications for gene therapy.
@ast
Direct immunologic activities of CpG DNA and implications for gene therapy.
@en
type
label
Direct immunologic activities of CpG DNA and implications for gene therapy.
@ast
Direct immunologic activities of CpG DNA and implications for gene therapy.
@en
prefLabel
Direct immunologic activities of CpG DNA and implications for gene therapy.
@ast
Direct immunologic activities of CpG DNA and implications for gene therapy.
@en
P1476
Direct immunologic activities of CpG DNA and implications for gene therapy.
@en
P2093
P356
10.1002/(SICI)1521-2254(199901/02)1:1<56::AID-JGM5>3.3.CO;2-Y
P577
1999-01-01T00:00:00Z